FILE PHOTO: An employee works on a vaccine based on the monkeypox vaccine that has already been developed by the vaccine company Bavarian Nordic at a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo
